Cargando…

2-[(18)F]FDG PET in the Management of Radioiodine Refractory Differentiated Thyroid Cancer in the Era of Thyrosin-Kinases Inhibitors: A Real-Life Retrospective Study

Purpose To evaluate the role of 2-[(18)F]FDGPET/CT in the follow-up of radioiodine refractory thyroid cancer (RR-TC). Methods Forty-six 2-[(18)F]FDGPET/CT scans from 14 RR-TC patients were considered. Thyroid function tests: thyroglobulin (Tg), levothyroxine (LT4), and tyrosine-kinases inhibitors (T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gay, Stefano, Raffa, Stefano, De’Luca di Pietralata, Anna, Bauckneht, Matteo, Vera, Lara, Miceli, Alberto, Albertelli, Manuela, Morbelli, Silvia, Giusti, Massimo, Ferone, Diego
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870858/ https://www.ncbi.nlm.nih.gov/pubmed/35204596 http://dx.doi.org/10.3390/diagnostics12020506

Ejemplares similares

Metabolic signature of hyposmia after mild COVID-19: An [18]F-FDG-pet study
por: Pardini, Matteo, et al.
Publicado: (2021)

Positron Emission Tomography (PET) Imaging of Multiple Myeloma in a Post-Treatment Setting
por: Ferrarazzo, Giulia, et al.
Publicado: (2021)

(18)F-FDG-PET/CT in Patients with Advanced, Radioiodine Refractory Thyroid Cancer Treated with Lenvatinib
por: Ahmaddy, Freba, et al.
Publicado: (2021)

Positron Emission Tomography-Based Response to Target and Immunotherapies in Oncology
por: Donegani, Maria Isabella, et al.
Publicado: (2020)

Beyond the Prognostic Value of 2-[(18)F]FDG PET/CT in Prostate Cancer: A Case Series and Literature Review Focusing on the Diagnostic Value and Impact on Patient Management
por: Borea, Roberto, et al.
Publicado: (2022)

The Elusive Link Between Cancer FDG Uptake and Glycolytic Flux Explains the Preserved Diagnostic Accuracy of PET/CT in Diabetes
por: Cossu, Vanessa, et al.
Publicado: (2020)

Neuroendocrine Differentiation of Prostate Cancer Is Not Systematically Associated with Increased 18F-FDG Uptake
por: Bauckneht, Matteo, et al.
Publicado: (2021)

Role of Baseline and Post-Therapy 18F-FDG PET in the Prognostic Stratification of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated with Radium-223
por: Bauckneht, Matteo, et al.
Publicado: (2019)

Tenosynovial Giant Cell Tumor of Foot in a Patient with Radioiodine-Refractory Thyroid Cancer: Imaging Findings on FDG-PET/CT, MRI, and Radioiodine Scan
por: Loharkar, Sarvesh, et al.
Publicado: (2022)

Salvage surgery for cervical radioiodine refractory (18)F-FDG-PET positive recurrence of papillary thyroid cancer
por: Chiapponi, C, et al.
Publicado: (2021)

Concomitant Prostate Cancer and Hodgkin Lymphoma: A Differential Diagnosis Guided by a Combined 68Ga-PSMA-11 and 18F-FDG PET/CT Approach
por: Miceli, Alberto, et al.
Publicado: (2021)

(18)F-FDG-PET correlates of aging and disease course in ALS as revealed by distinct PVC approaches
por: Ferraro, Pilar M., et al.
Publicado: (2022)

Impact of microscopic extrathyroidal extension on differentiated thyroid cancer post-surgical risk of recurrence: a retrospective analysis
por: Patti, L., et al.
Publicado: (2023)

Beyond Covid-19 vaccination-associated pitfalls on [(18)F]Fluorodeoxyglucose (FDG) PET: a case of a concomitant sarcoidosis
por: Bauckneht, Matteo, et al.
Publicado: (2021)

Comparative diagnostic accuracy of 18F-FDG PET/CT for breast cancer recurrence
por: Piva, Roberta, et al.
Publicado: (2017)

FDG uptake tracks the oxidative damage in diabetic skeletal muscle: An experimental study
por: Bauckneht, Matteo, et al.
Publicado: (2019)

Impact of Vitamin D Deficiency on Tumor Aggressiveness in Neuroendocrine Neoplasms
por: Albertelli, Manuela, et al.
Publicado: (2023)

"Present and future of immunotherapy in Neuroendocrine Tumors"
por: Albertelli, Manuela, et al.
Publicado: (2021)

Mechanisms underlying the predictive power of high skeletal muscle uptake of FDG in amyotrophic lateral sclerosis
por: Marini, Cecilia, et al.
Publicado: (2020)

Radioiodine refractoriness score: A multivariable prediction model for postoperative radioiodine‐refractory differentiated thyroid carcinomas
por: Li, Genpeng, et al.
Publicado: (2018)

The prognostic power of 18F-FDG PET/CT extends to estimating systemic treatment response duration in metastatic castration-resistant prostate cancer (mCRPC) patients
por: Bauckneht, Matteo, et al.
Publicado: (2021)

Defining Radioiodine-Refractory Differentiated Thyroid Cancer: Efficacy and Safety of Lenvatinib by Radioiodine-Refractory Criteria in the SELECT Trial
por: Kiyota, Naomi, et al.
Publicado: (2017)

Biological and Biochemical Basis of the Differential Efficacy of First and Second Generation Somatostatin Receptor Ligands in Neuroendocrine Neoplasms
por: Gatto, Federico, et al.
Publicado: (2019)

Spinal cord hypermetabolism extends to skeletal muscle in amyotrophic lateral sclerosis: a computational approach to [18F]-fluorodeoxyglucose PET/CT images
por: Bauckneht, Matteo, et al.
Publicado: (2020)

GH Replacement in the Elderly: Is It Worth It?
por: Ricci Bitti, Silvia, et al.
Publicado: (2021)

Brain Metabolic Correlates of Persistent Olfactory Dysfunction after SARS-Cov2 Infection
por: Donegani, Maria Isabella, et al.
Publicado: (2021)

Use of multikinase inhibitors/lenvatinib concomitant with radioiodine for the treatment of radioiodine refractory differentiated thyroid cancer
por: Herranz, Urbano Anido
Publicado: (2022)

Spleen Perfusion as an Index of Gender Impact on Sympathetic Nervous System Response to Exercise
por: Lanfranchi, Francesco, et al.
Publicado: (2021)

Prognostic value of immunotherapy-induced organ inflammation assessed on (18)FDG PET in patients with metastatic non-small cell lung cancer
por: Humbert, Olivier, et al.
Publicado: (2022)

A Score-Based Approach to (18)F-FDG PET Images as a Tool to Describe Metabolic Predictors of Myocardial Doxorubicin Susceptibility
por: Bauckneht, Matteo, et al.
Publicado: (2017)

Feasibility of Apatinib in Radioiodine-Refractory Differentiated Thyroid Carcinoma
por: Du, Wei, et al.
Publicado: (2022)

Hurthle Cells Adenoma With Distant Metastases Refractory to Radioiodine
por: Rosario, Pedro Weslley, et al.
Publicado: (2021)

Molecular Theranostics in Radioiodine-Refractory Differentiated Thyroid Cancer
por: Petranović Ovčariček, Petra, et al.
Publicado: (2023)

Usefulness of PET/CT with (18)F-FDG in Patients with Differentiated Thyroid Carcinoma after Radioiodine Therapy: An Italian Multicenter Study
por: Filippi, Luca, et al.
Publicado: (2021)

Emerging Targets in Pituitary Adenomas: Role of the CXCL12/CXCR4-R7 System
por: Barbieri, Federica, et al.
Publicado: (2014)

Quantitative ([18])FDG PET asymmetry features predict long-term seizure recurrence in refractory epilepsy
por: Kini, Lohith G., et al.
Publicado: (2021)

Long-term outcome of low-activity radioiodine administration preceded by adjuvant recombinant human TSH pretreatment in elderly subjects with multinodular goiter
por: Giusti, Massimo, et al.
Publicado: (2009)

Early prediction of treatment outcome for lenvatinib using (18)F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma refractory to radioiodine treatment: a prospective, multicentre, non-randomised study
por: Takeuchi, Satoshi, et al.
Publicado: (2023)

A comparative cross-sectional study on sleep quality in patients with a history of differentiated thyroid carcinoma and its correlation with quality of life
por: Teliti, Marsida, et al.
Publicado: (2021)

Safety and tolerability of sorafenib in patients with radioiodine-refractory thyroid cancer
por: Worden, Francis, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_soanr8igpnfqjuedfpb2s1dv1u